Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts. Determination of the in Vivo Allergenic Potency in Histamine Equivalent Units (HEP).

NCT05533385 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT05533385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05533385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts. Determination of the in Vivo Allergenic Potency in Histamine Equivalent Units (HEP).
Lead sponsor
Inmunotek S.L.
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2023
Completion date
January 22, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic reaction, allergic skin reaction, allergy pollen